About US
Contact us
-
Cipla buying control of South Africa's 3rd largest drugmakerCipla Medpro CEO Jerome Smith may be gone, but his plans are not forgotten at the South African company. Weeks after he resigned in a fight with his board over pay raises he treated himself to, the co2012/11/22
-
Novartis fast production, cell-culture flu vaccine OK'd by FDAThe FDA today gave Novartis ($NVS) the go-ahead for a seasonal flu vaccine that is made from animal cell culture instead of chicken eggs, a process that can turn out vaccine pronto in the event of a p2012/11/22
-
Overnight success proves elusive for oral MS drugsTheoretically, the advent of oral MS treatments was supposed to drain sales away from less-convenient injectables--and quickly. In practice, patients and doctors have proven more cautious about the n2012/11/21
-
Glaxo nabs FDA approval for hep C remedy PromactaGlaxoSmithKline has won an FDA approval to market Promacta to hepatitis C patients whose low blood platelet counts prevent them from taking interferon, a commonly used treatment linked to a host of s2012/11/21
-
Novo Nordisk, largest Nordic company, shoots for top drugmakerNovo Nordisk's CEO Lars Sorensen acknowledges there was an odd element of good fortune for the drugmaker in becoming the largest company in the Nordic region by capitalization and among the top 10 dr2012/11/20
-
Illumina gets dose of its own medicine, spurned by Complete GenomicsGene sequencing specialist Illumina ($ILMN) got a dose of its own medicine.The drugmaker, which earlier this year fought off a hostile takeover from Roche ($RHHBY), was itself spurned by a takeover t2012/11/20
-
US committee recommends approval of GSK’s bird flu vaccineA US health regulator has recommended the approval of GlaxoSmithKline's new bird flu vaccine. The US FDA's Vaccines and Related Biological Products Advisory Committee voted unanimously that the2012/11/19
-
Bayer's $1.2B bid for vitamin maker topped by U.K. groupThe aggressive diversification campaign of Bayer CEO Marijn Dekkers has been checked, at least temporarily, by Reckitt Benckiser Group, which has moved on Schiff Nutrition International with a bid of2012/11/19
-
Catalent, Cevec in Cell Line Sales PactCatalent Pharma Solutions and Cevec Pharmaceuticals have entered a commercial cell line sales agreement for recombinant human alpha-1 antitrypsin (hAAT). The companies have also signed a joint develop2012/11/16
-
GlaxoSmithKline to pay out $90M more for Avandia claimsGlaxoSmithKline ($GSK） has shaken off more litigation tied to the safety of its Avandia diabetes drug by agreeing to pay $90 million in a settlement with 38 states. It did so without contrition. A re2012/11/16